The herbicide atrazine is probably the most widely used pesticide in the world ([@b4-ehp0114s1-000134]; [@b56-ehp0114s1-000134]; [@b59-ehp0114s1-000134]; [@b74-ehp0114s1-000134]). As a result, it is the most common contaminant of groundwater and surface water ([@b4-ehp0114s1-000134]; [@b15-ehp0114s1-000134]; [@b16-ehp0114s1-000134]; [@b19-ehp0114s1-000134]; [@b22-ehp0114s1-000134]; [@b18-ehp0114s1-000134], [@b21-ehp0114s1-000134], [@b20-ehp0114s1-000134]; [@b41-ehp0114s1-000134]; [@b49-ehp0114s1-000134]; [@b50-ehp0114s1-000134], [@b51-ehp0114s1-000134]; [@b59-ehp0114s1-000134]; [@b62-ehp0114s1-000134]; [@b64-ehp0114s1-000134]; [@b68-ehp0114s1-000134]; [@b71-ehp0114s1-000134]; [@b80-ehp0114s1-000134]; [@b81-ehp0114s1-000134]). Atrazine contamination can spread well beyond areas where it is applied ([@b10-ehp0114s1-000134]; [@b31-ehp0114s1-000134]; [@b56-ehp0114s1-000134]; [@b59-ehp0114s1-000134]; [@b60-ehp0114s1-000134]; [@b80-ehp0114s1-000134]; [@b83-ehp0114s1-000134]), traveling up to 1,000 km ([@b83-ehp0114s1-000134]), and can persist for decades after its use is halted ([@b31-ehp0114s1-000134]; [@b37-ehp0114s1-000134]). Atrazine is also a potent endocrine disruptor that both chemically castrates and feminizes exposed male amphibians at ecologically relevant concentrations (as low as 0.1 ppb).

The adverse effects of atrazine on amphibian gonadal development were first demonstrated by [@b78-ehp0114s1-000134], who showed that atrazine decreased testicular volume (*p* = 0.004), decreased the frequency of nursing cells (*p* \< 0.0001), and decreased the number of primary spermatogonial nests (*p* \< 0.0001) in African clawed frogs (*Xenopus laevis*) after only 48 hr of exposure. [@b63-ehp0114s1-000134] reported that atrazine demasculinized exposed male larvae, causing a significant reduction in laryngeal size in males (*p* = 0.045) in the same species (*X. laevis*). Our laboratory has shown that atrazine disrupted male gonadal development (*p* \< 0.05) at concentrations as low as 0.1 ppb in *X. laevis* larvae ([@b31-ehp0114s1-000134]) and confirmed findings reported by [@b63-ehp0114s1-000134]. [@b5-ehp0114s1-000134] further confirmed these laboratory's findings, showing similar gonadal abnormalities (multiple testes, *p* = 0.0003; hermaphroditism, *p* = 0.0042) at similar frequencies and over similar atrazine concentrations ([@b28-ehp0114s1-000134]). The comparisons between the two studies and the graphic presentation were described by [@b28-ehp0114s1-000134]. We then showed that atrazine feminized leopard frogs (*Rana pipiens*) in the laboratory (*p* \< 0.001), inducing testicular oogenesis ([@b32-ehp0114s1-000134], [@b33-ehp0114s1-000134]).

The laboratory findings described above were supported by a field study reported in [@b65-ehp0114s1-000134], which suggested that atrazine was associated with gonadal malformations (testicular oocytes) in cricket frogs (*Acris crepitans*) (*p* = 0.07). This work was followed by our field study in leopard frogs (*R. pipiens*) ([@b32-ehp0114s1-000134], [@b33-ehp0114s1-000134]) showing a similar association between atrazine contamination and feminized frogs in the wild (*p* \< 0.05). Further, [@b10-ehp0114s1-000134] showed that feminized *X. laevis* males were associated with atrazine contamination (≥ 0.1 ppb) in the wild in South Africa in both corn-growing and non-corn-growing regions (although no noncontaminated, atrazine-free areas were examined for reference). Given the adverse effects of atrazine at such low concentrations, the ubiquity of atrazine contamination, and its persistence in the environment, the impact on amphibian populations can be quite significant. The present study is a first step in understanding atrazine's mechanism of action in amphibians.

Estrogens feminize exposed male amphibians in multiple species ([@b7-ehp0114s1-000134]; [@b27-ehp0114s1-000134]; [@b66-ehp0114s1-000134]; [@b84-ehp0114s1-000134]), including the species feminized by atrazine in the laboratory studies described above (*X. laevis* and *R. pipiens*). Although atrazine has a negligible affinity for the estrogen receptor ([@b67-ehp0114s1-000134]), many studies have shown that atrazine exposure elevates estrogens in every species (and class of vertebrate) examined (see "Discussion"). Therefore, we hypothesized that atrazine may feminize amphibians via inappropriate estrogen synthesis in males after an increase in expression and/or activity of aromatase, the enzyme that converts androgens to estrogens ([Figure 1](#f1-ehp0114s1-000134){ref-type="fig"}) ([@b31-ehp0114s1-000134]). Alternatively, some malformations may result from a decrease in androgens (as a substrate for aromatase) or through one of the several other mechanisms by which atrazine decreases androgen levels and/or activity ([@b1-ehp0114s1-000134]; [@b46-ehp0114s1-000134], [@b47-ehp0114s1-000134], [@b48-ehp0114s1-000134], [@b45-ehp0114s1-000134]; [@b72-ehp0114s1-000134]). As a first step to testing these hypotheses, we describe here the types of gonadal malformations observed with atrazine exposure in *X. laevis* and compare the types of malformations with morphologies produced by exposure to the antiandrogen cyproterone acetate (CPA) and exogenous estrogen \[17β-estradiol (E~2~)\].

Materials and Methods
=====================

Materials
---------

Atrazine (2-chloro-4-ethylamino-6-isopropylamine-1,3,5-triazine) was obtained from Chemservice Inc. (Chester, PA). Cyproterone acetate (6-chloro-1β,2β-dihydro-17-hydroxy-3′*H*-cyclopropa\[1,2\]-pregna-1,4,6-triene-3,20-dione acetate) and 17β-estradiol (1,3,5-estratrien-3,17-β-diol), human choriogonadotropin, and benzocaine (ethyl-*p*-amino benzoate) were purchased from Sigma Chemical Co. (St. Louis, MO). All other reagents and histology supplies were obtained from Fisher Scientific (Fairlawn, NJ) except where indicated.

Animal breeding and larval care
-------------------------------

Adult frogs for breeding were obtained from a long-term captive colony maintained at the University of California, Berkeley. For each experiment, three males and three females were injected with human choriogonadotropin (1,000 IU) 6 hr before harvesting gametes. Eggs were manually stripped from the females and fertilized *in vitro* in 0.3× modified mammalian Ringer's solution by using sperm obtained from the dissected testes of the three males. Embryos were allowed to hatch and after 4 days apportioned into experimental tanks, five at a time, until all tanks contained 30 larvae. Larvae were raised and experiments conducted in covered plastic mouse boxes in 4 L of 10% (0.1×) aerated Holtfreter's solution ([@b39-ehp0114s1-000134]). All experiments were conducted at 22°C (± 1) and rooms were maintained on a 12/12-hr light/dark cycle (lights on at 0600 hr). Double distilled, ultraviolet-treated, carbon-filtered, deionized water used to make Holtfreter's solution was certified atrazine-free by three laboratories (detection limit at least 0.1 ppb): one university laboratory (Iowa State Hygienics Laboratory, University of Iowa, Iowa City, IA), one government laboratory (U.S. Geological Survey, Denver, CO; detection limit, 0.02 ppb), and one private laboratory (PTRL West, Richmond, CA) as described previously ([@b31-ehp0114s1-000134], [@b32-ehp0114s1-000134], [@b33-ehp0114s1-000134]). Water was also analyzed by the U.S. Geological Survey and found to be free (\< 0.025 ppb) of 21 other triazine herbicides or metabolites, as well as free of alachlor, acetochlor, metolachlor, glyphosate, nicosulfuron, cyhalothrin, cyfluthrin, metalaxyl, propiconizole, and diazinon. Larvae were fed a solution of homogenized Purina rabbit chow (Purina Mills LLC, St. Louis, MO) daily, and the amount was adjusted as larvae grew to ensure that animals were fed ad libitum. All treatments (described below) were replicated three times (three 4-L tanks of 30 larvae each for a total of 90 larvae per treatment per experiment), and all tanks were color coded so that personnel delivering treatments and caring for animals were not aware of which groups were controls and which were experimental groups. Tanks were cleaned and solutions renewed every 3 days except during the E~2~ experiments (described below), when tanks were changed and solutions renewed daily. At each solution change, tanks were rotated around the rack to prevent position effects. Larvae were monitored daily, and animals at the end of metamorphosis \[Niewkoop and Faber (NF) stage 66; [@b61-ehp0114s1-000134]\] were removed daily, euthanized in a 0.2% benzocaine solution, weighed, measured, fixed in Bouin's fixative for 48 hr, and then preserved and stored in 70% ethanol until analysis, as described previously ([@b31-ehp0114s1-000134]). Upon preservation, each specimen was given a coded specimen number so that personnel conducting final analyses were not aware of the color or treatment type for each individual.

Experimental design
-------------------

We compared gonadal malformations induced by 0.1, 0.4, 0.8, 1, and 25 ppb atrazine \[as reported by [@b31-ehp0114s1-000134]\] for morphologies resulting from steroid or steroid antagonist exposure. Two alternative but not mutually exclusive hypotheses were tested: *a*) one or more of the types of gonadal malformations induced by atrazine represented "demasculinization" or loss of androgens, and/or *b*) one or more of the types of gonadal malformations represented feminization as a result of inappropriate estrogen production. We conducted two experiments to distinguish between these possibilities.

### Experiment 1: effects of exposure to the antiandrogen CPA

Here, we tested the possibility that one or more of the atrazine-induced malformations represented demasculinization of the gonads as a result of androgen depletion. Larvae were treated with the androgen receptor antagonist CPA (5 mg/mL) throughout development (NF stages 50--66) to examine the effect of demasculinization on the developing gonads. At NF stage 66, animals were euthanized, fixed, and preserved. Sex was determined and gonads analyzed as described below. CPA was predissolved in methanol, and controls for this experiment were treated with an equal amount of methanol. Compounds were added to 16.5 L of 0.1× Holtfreter's solution (final methanol concentration, 0.004% for all treatments), and the solution was divided among the three replicates. We also maintained a three-replicate set of untreated larvae (no solvent) for comparison with solvent-treated controls.

### Experiment 2: effects of short-term E~2~ exposure

We tested the possibility that one or more of the atrazine-induced malformations represented partial feminization of the developing gonad. Although it is well known that estrogens induce 100% females in *X. laevis* ([@b7-ehp0114s1-000134]; [@b24-ehp0114s1-000134]; [@b27-ehp0114s1-000134]), the concentration and timing of exposure are important for complete sex reversal of all exposed individuals. We treated larvae with E~2~ (100 μg/L) for 7 days (NF stages 50--53), 14 days (NF stages 50--55), or 49 days (NF stages 50--66) ([Figure 2](#f2-ehp0114s1-000134){ref-type="fig"}). Holtfreter's solution was changed daily (as opposed to every 3 days) because previous studies showed that tadpoles rapidly metabolize exogenous estrogens ([@b34-ehp0114s1-000134]). To deliver E~2~, the steroid was predissolved in 100% ethanol (final ethanol concentration, 0.004%), and the solution was divided among the nine replicates (three replicates each, representing each treatment regime described above). Controls were treated with an equal amount of ethanol for comparison with E~2~. We also maintained a three-replicate set of untreated larvae (no solvent) for comparison with solvent-treated controls. At NF stage 66, animals were euthanized, fixed in Bouin's, and preserved in 70% ethanol. Sex was determined by gross morphology and histology as described below.

Gonadal analysis
----------------

Gonadal type (ovaries or testes) was scored using a Nikon SMZ 10A dissecting scope, fitted with a 0.5× lens (Technical Instruments, Burlingame, CA). A subset of animals (*n* = 150) was prepared for histologic analysis following procedures described by [@b31-ehp0114s1-000134]. Initially, we identified and characterized gonadal malformations (morphologies that occurred in atrazine-treated animals but not in controls) by identifying anomalies in 30 animals treated with 25 ppb atrazine. An atlas of these malformations (see "Results") was used to score and determine the frequency of malformations in controls and in animals treated with a range of atrazine concentrations.

Statistical analysis
--------------------

Effects on sex ratios and frequency of gonadal malformations were analyzed using the *G*-test as described by [@b73-ehp0114s1-000134]. First, we determined whether the sex ratio in untreated controls differed from the expected ratio of 50:50:0, male:female:malformed, after conducting a test of heterogeneity (*G*~H~) to determine whether there were any tank effects. Next, we tested each set of controls (from the three experiments) to determine if there were significant differences between the sex ratios of ethanol or methanol-treated larvae and untreated controls. Then, we examined each experiment separately (atrazine, CPA, and E~2~ treatments). We first conducted a test for heterogeneity, and if significant effects were found (*p* \< 0.05), we then examined each experimental group using a test of heterogeneity to determine if there were any tank effects within each treatment. Finally, we examined each treatment group for deviation from the expected sex ratios, using results from the solvent-only controls to generate the expected ratios. Statistical significance was accepted at *p* \< 0.05.

Results
=======

Normal gonadal differentiation
------------------------------

Under the described conditions in our laboratory, gonadal differentiation occurs between NF stages 52 and 54, as determined by histologic analysis. At metamorphosis (complete tail reabsorption, NF stage 66), males and females can be distinguished by gross morphology of the gonads under the dissecting scope. Testes are shorter than ovaries (approximately one-third the length of the kidney) and lack pigment ([Figure 3A](#f3-ehp0114s1-000134){ref-type="fig"}). Ovaries extend the entire length of the kidney and are lobed and interspersed with melanin ([Figure 3B](#f3-ehp0114s1-000134){ref-type="fig"}). Histologically, testes are characterized by medullary development and distinguishable testicular lobules ([Figure 3C](#f3-ehp0114s1-000134){ref-type="fig"}). Ovaries are characterized by cortical development with a central ovarian cavity surrounded by a ring of connective tissue ([Figure 3D](#f3-ehp0114s1-000134){ref-type="fig"}). Oocytes are not observed in females even at NF stage 66 under the conditions used in our laboratory. In addition to the animals examined here, this characterization is based on more than 10,000 observations over 10 years of study in our laboratory and consistent with multiple reports from the literature dating back to 1953 ([@b24-ehp0114s1-000134]; [@b27-ehp0114s1-000134], [@b30-ehp0114s1-000134]). In the present study, analysis of untreated controls and all solvent-only controls revealed that none differed from the expected sex ratio 50:50:0, male:female:malformed gonads (*p* \> 0.5 in all cases). Analysis of heterogeneity revealed that there were no tank effects among controls, neither solvent (ethanol or methanol) affected the sex ratio, and control groups from across the three experiments were homogeneous (*G*~H~ = 8.45, *df* = 22, *p* \> 0.995).

Types and frequencies of gonadal malformations induced by atrazine
------------------------------------------------------------------

By definition, "gonadal malformations" were defined initially as morphologies observed in atrazine-exposed larvae but not in controls. Gonadal malformations observed in atrazine-treated animals included two types of polygonadism (maximum six gonads): single-sex polygonadism (SSP; previously described as broken, lobed, or discontinuous testes; [@b5-ehp0114s1-000134]; [@b31-ehp0114s1-000134], [@b32-ehp0114s1-000134]), where animals contained more than two distinct testes ([Figure 4](#f4-ehp0114s1-000134){ref-type="fig"}); and hermaphroditism, where individuals developed multiple combinations of testes and ovaries. Three morphologic types of hermaphrodites were observed. Morphologies included mixed hermaphrodites ([Figure 5](#f5-ehp0114s1-000134){ref-type="fig"}) in which animals contained multiple testes and ovaries, lateral hermaphrodites ([Figure 6](#f6-ehp0114s1-000134){ref-type="fig"}) in which animals contained only one pair of gonads with a complete testis on one side and an ovary on the other (no noted bias in which side was male and which was female), and rostral-caudal hermaphrodites ([Figure 7](#f7-ehp0114s1-000134){ref-type="fig"}) in which animals had two pair of gonads: one sex anterior and the other posterior. In a final type of malformation, animals had a single pair of gonads that appeared to be ovaries but lacked pigment ([Figure 8](#f8-ehp0114s1-000134){ref-type="fig"}). In some cases, the nonpigmented gonads were lobed like an ovary, whereas in others, the gonads had only shallow lobes or no lobes at all. Nonpigmented ovaries were the most common abnormality in atrazine-exposed animals. The second most common malformation was SSP. The frequency of all malformations varied between concentrations and the highest number of total malformations occurred at 1 ppb, although nonpigmented ovaries occurred at the highest frequency at 0.4 ppb, whereas hermaphrodites and SSP occurred at the highest frequency at 1 ppb ([Figure 9](#f9-ehp0114s1-000134){ref-type="fig"}). Atrazine caused a significant increase in the number of malformations in all cases (*p* \< 0.001; [Table 1](#t1-ehp0114s1-000134){ref-type="table"}). Although malformations were initially defined as morphologies found in atrazine-exposed animals but absent from controls, three methanol-treated controls from one replicate and a single ethanol-exposed animal (1%) with nonpigmented ovaries were later identified.

Comparison of atrazine-induced malformations with effects of E~2~ and CPA
-------------------------------------------------------------------------

### Experiment 1

Exposure to the androgen receptor antagonist (CPA) did not result in hermaphroditism or SSP but produced a high percentage of animals (36%) with nonpigmented ovaries (*G* = 72.41, *df* = 2, *p* \< 0.001), similar to the morphology produced by atrazine ([Figures 10](#f10-ehp0114s1-000134){ref-type="fig"}, [11](#f11-ehp0114s1-000134){ref-type="fig"}).

### Experiment 2

Exposure to E~2~ for the entire larval period resulted in 100% females as determined by gross gonadal morphology and confirmed by histologic analysis. Larvae treated for 7 days (NF stages 50--53) or 14 days (NF stages 50--55) showed incomplete sex reversal, resulting in SSP and hermaphroditism (*G* = 1052.30, *df* = 2, *p* \< 0.001 and *G* = 417.01, *df* = 2, *p* \< 0.001, respectively) similar to morphologies observed with atrazine exposure ([Figure 12](#f12-ehp0114s1-000134){ref-type="fig"}). The highest frequency of malformations occurred in the 7-day treatment ([Figure 13](#f13-ehp0114s1-000134){ref-type="fig"}). Nonpigmented ovaries were not observed with complete or partial exposure to E~2~.

Discussion
==========

The gonadal malformations described in the present study were grouped into two categories: SSP (multiple sex organs of one type) and hermaphroditism (multiple sex organs with a mixture of testes and ovaries). As described previously ([@b27-ehp0114s1-000134]), "primary sex differentiation" is the development of the undifferentiated (sometimes called "indifferent" or "bipotential") gonads into testes (male) or ovaries (female). Although used to mean many different things in common language, a true hermaphrodite (after the Greek *"*Hermaphroditus," the child of the mythical Hermes and Aphrodite who bore both male and female sex organs) is a single organism bearing both testicular and ovarian tissue. The organization of these tissues is not prescribed: there can be multiple organs or multiple tissue types within one organ. Historically, the term "intersex" has been used interchangeably with the term "hermaphrodite," and the two should be considered synonyms here. In the case of SSP, the terms "broken testes" and "lobed testes" have been used synonymously in the literature ([@b5-ehp0114s1-000134]; [@b31-ehp0114s1-000134], [@b32-ehp0114s1-000134]).

The gonadal morphologies associated with atrazine exposure described in the present study are consistent with effects described by [@b5-ehp0114s1-000134], who showed similar malformations (SSP and hermaphroditism) at similar frequencies induced by similar atrazine concentrations in *X. laevis* ([@b28-ehp0114s1-000134]). Other effects of atrazine in *X. laevis* (e.g., gamete reduction/gonadal dysgenesis; [@b78-ehp0114s1-000134], [@b79-ehp0114s1-000134]) were not reported in our work, but treatments and husbandry differed greatly, and animals were not examined for this type of malformation in our studies. Also, reports in a recent study ([@b42-ehp0114s1-000134]) suggested that as many as 57% of atrazine-treated and control male *X. laevis* have testicular oocytes at metamorphosis. Testicular oocytes (although observed in other species) were not observed in any of our analyses in *X. laevis* (treated or control) and, in fact, have not been reported in any other study in *X. laevis* dating back to the 1950s ([@b5-ehp0114s1-000134]; [@b7-ehp0114s1-000134]; [@b8-ehp0114s1-000134]; [@b24-ehp0114s1-000134]; [@b30-ehp0114s1-000134]; [@b55-ehp0114s1-000134]; [@b84-ehp0114s1-000134]). The single report that described these effects was based on larvae reared at near-lethal feminizing temperatures (10°C) during critical stages of gonadal development, which likely explains this isolated anomalous finding ([@b30-ehp0114s1-000134]).

Like most anurans, *X. laevis* does not have morphologically distinguishable sex chromosomes, so it is not possible to determine the genetic sex of the hermaphrodites by karyotype (are they genetic females with testes or genetic males with ovaries?). Exposure to estrogens throughout the larval period results in 100% females in *X. laevis* (produces ovaries in genetic males) ([@b7-ehp0114s1-000134]), but female sex differentiation is not altered by exogenous sex steroids in *X. laevis*: exogenous androgens induce testicular development in genetic females of other anuran species ([@b27-ehp0114s1-000134]), but androgens do not affect primary sex differentiation in genetic female *X. laevis* larvae ([@b27-ehp0114s1-000134]). Given the immutability of ovarian differentiation in female *X. laevis* larvae, we suggest that the hermaphrodites represent males that have been partially feminized rather than females that have been masculinized. The observation that SSP occurs in males only (females with multiple ovaries are not observed) further suggests that only males are affected. In addition, in other species, female secondary sex characteristics, including oocytes ([@b29-ehp0114s1-000134]; [@b32-ehp0114s1-000134], [@b33-ehp0114s1-000134]; [@b65-ehp0114s1-000134]), vitellogenin ([@b57-ehp0114s1-000134]), and skin coloration ([@b54-ehp0114s1-000134]), are observed in male amphibians exposed to atrazine, but females with masculine secondary sex features have not been observed.

Further supporting our suggestion that the atrazine only affects male gonads, [@b5-ehp0114s1-000134], who reported significant induction of similar gonadal malformations, observed that the frequency of animals with gonadal malformations was matched by a paucity of males in their studies and suggested that only males are affected by atrazine:

> The effects seem to be restricted to males, since the percentage reduction in males was proportional to the increase in intersex animals and atrazine did not affect the percentage of females, which remained at 50%.

Our findings with atrazine are in agreement with those of [@b5-ehp0114s1-000134], and we similarly suggest that the hermaphrodites represent demasculinized/feminized males, as opposed to masculinized/defeminized females.

Given that only males are affected, the true frequency of affected *X. laevis* in our previous report was 32--40% of the exposed males (hermaphrodites + SSP + unpigmented ovaries) as opposed to 16--20% of the total exposed population reported in [@b31-ehp0114s1-000134]. Further, in the [@b5-ehp0114s1-000134], the frequency of gonadal malformations (SSP and hermaphrodites only) ranged from 10 to 26% of the males \[compared with 10--28% (SSP and hermaphrodites only) in our studies\] in a concentration-dependent manner. The frequency reported by [@b5-ehp0114s1-000134] did not include nonpigmented ovaries; thus, the frequency of gonadal malformations (already 3-fold higher at some concentrations when only hermaphrodites and SSP are considered; [@b28-ehp0114s1-000134]) was significantly higher than frequencies observed in our studies.

The malformations induced by atrazine in *X. laevis* ([@b5-ehp0114s1-000134]; [@b31-ehp0114s1-000134]) were reproduced in the present study by exposure to an antiandrogen (nonpigmented ovaries) or exposure to exogenous estrogen (hermaphroditism and SSP). The ability of antiandrogens and estrogens to produce the same types of malformations as atrazine provides support for the aromatase hypothesis: atrazine-exposed larvae suffer from a combination of androgen reduction and increased estrogen production. The highly significant induction of unpigmented ovaries by the antiandrogen CPA suggests that this malformation is the result of androgen depletion in atrazine-treated larvae, potentially as a result of the induction of aromatase (which uses androgen as a substrate for estrogen production), although atrazine reduces androgens through other mechanisms ([@b1-ehp0114s1-000134]; [@b46-ehp0114s1-000134], [@b47-ehp0114s1-000134], [@b48-ehp0114s1-000134], [@b45-ehp0114s1-000134]; [@b72-ehp0114s1-000134]). It is also notable that the frequency of females was low in the CPA-treated group, however. The high mortality in the CPA treatment (42%; [Figure 11](#f11-ehp0114s1-000134){ref-type="fig"}) may explain the sex ratio skew (differential mortality with females more susceptible), but this hypothesis needs to be further tested.

[@b57-ehp0114s1-000134] showed that atrazine affects aromatase in *X. laevis*, although they were not able to track aromatase induction with malformations in males consistently (Tooi O, personal communication). Another research group was unable to show a significant induction of aromatase in captive *X. laevis* adults, but as reported by the authors, the study was not robust enough to identify such differences: "Based on the relatively low power to determine significant differences between plasma hormone concentrations in atrazine treated and control frogs it cannot be ruled out entirely that there have been some minor influences of atrazine treatment on plasma E~2~ or T \[testosterone\]" ([@b36-ehp0114s1-000134]). Consistent with our findings and hypotheses presented in the present study, this same research group detected negative relationships between plasma testosterone levels and atrazine in *X. laevis* in the wild. Although no relationship between atrazine and aromatase activity was reported, [@b36-ehp0114s1-000134] concluded that "effects of atrazine or co-applied pesticides on sex steroid homeostasis cannot be excluded at this point." It should also be pointed out that localized induction of aromatase and subsequent developmental effects of the resulting estrogens do not require (and often are not associated with) elevated plasma hormone levels. For example, in breast cancer, uterine cancer, endometriosis ([@b3-ehp0114s1-000134]), and prostate cancer ([@b14-ehp0114s1-000134]) or in normal processes such as sex differentiation of the brain in fish ([@b25-ehp0114s1-000134]), birds ([@b2-ehp0114s1-000134]), and mammals ([@b40-ehp0114s1-000134]), local induction of aromatase has permanent effects on cell and tissue differentiation through paracrine, autocrine, and even intracrine actions but does not result in changes in plasma sex steroid hormones.

Most significant, the proposed mechanism of action for atrazine (aromatase induction) has been observed in all vertebrate classes examined: aromatase gene expression (cytochrome P450-19 hydroxylase) is increased by atrazine in *X. laevis* metamorphs ([@b57-ehp0114s1-000134]), human cells ([@b70-ehp0114s1-000134], [@b69-ehp0114s1-000134]), and human tissues ([@b17-ehp0114s1-000134]; [@b38-ehp0114s1-000134]). Atrazine induces aromatase activity and/or expression in fish ([@b58-ehp0114s1-000134]; [@b75-ehp0114s1-000134]; [@b86-ehp0114s1-000134]), amphibians ([@b57-ehp0114s1-000134]), and two orders of reptiles (alligators, [@b9-ehp0114s1-000134]; turtles, [@b43-ehp0114s1-000134]). Atrazine increases circulating estrogen levels in rodents ([@b13-ehp0114s1-000134]; [@b12-ehp0114s1-000134]; [@b76-ehp0114s1-000134]; [@b85-ehp0114s1-000134]) and is associated with estrogen-like activities and estrogen-dependent effects in fish ([@b58-ehp0114s1-000134]; [@b75-ehp0114s1-000134]), amphibians ([@b5-ehp0114s1-000134]; [@b6-ehp0114s1-000134]; [@b10-ehp0114s1-000134]; [@b26-ehp0114s1-000134]; [@b28-ehp0114s1-000134], [@b29-ehp0114s1-000134]; [@b31-ehp0114s1-000134], [@b32-ehp0114s1-000134], [@b33-ehp0114s1-000134]; [@b65-ehp0114s1-000134]; [@b78-ehp0114s1-000134], [@b79-ehp0114s1-000134]), reptiles ([@b9-ehp0114s1-000134]; [@b43-ehp0114s1-000134]), and birds ([@b53-ehp0114s1-000134]; Matsushita S, personal communication). Atrazine also increases estrogen-sensitive reproductive cancers in rodents ([@b13-ehp0114s1-000134]; [@b12-ehp0114s1-000134]; [@b76-ehp0114s1-000134]; [@b85-ehp0114s1-000134]) and is associated with similar estrogen-sensitive reproductive cancers in humans ([@b44-ehp0114s1-000134]; [@b52-ehp0114s1-000134]). Likewise, the demasculinization is consistent with the chemical castration (testosterone depletion) and decreased milt induced by atrazine in fish ([@b58-ehp0114s1-000134]) and adult *X. laevis* ([@b31-ehp0114s1-000134]), androgen depletion and decrease in sperm in rodents ([@b1-ehp0114s1-000134]; [@b23-ehp0114s1-000134]; [@b47-ehp0114s1-000134]; [@b82-ehp0114s1-000134]), and the association between poor semen quality and atrazine exposure in human males ([@b77-ehp0114s1-000134]). Thus, the combined demasculinization (depletion of androgens) and feminization (elevation of estrogens) has been demonstrated in fish, amphibians, reptiles, and mammals (including humans). With a single study showing similar effects in birds ([@b53-ehp0114s1-000134]; Matsushita S, personal communication), this mechanism has been demonstrated now in all vertebrate classes with the exception of Chondrichthyes (e.g., sharks and rays) and agnathid (e.g., lampreys), which have not been examined. These data collected independently across all vertebrate classes examined support the warning of [@b70-ehp0114s1-000134], who first reported atrazine's mechanism of action in a human cell line:

> A logical concern would be that exposure to triazine herbicides, which are produced and used in large quantities, and are ubiquitous environmental contaminants, may similarly contribute to estrogen-mediated toxicities and inappropriate sexual differentiation.

This article is part of the monograph "The Ecological Relevance of Chemically Induced Endocrine Disruption in Wildlife."
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![Proposed mechanism of atrazine action on amphibians. The induction of aromatase results in a decrease in androgens (aromatase substrate) and a subsequent increase in estrogens (aromatase product). Atrazine thus demasculinizes (chemically castrates) and feminizes amphibians. Molecular and endocrine support for the proposed mechanism has been demonstrated in amphibians as well as all other vertebrate classes examined (see "Discussion").](ehp0114s1-000134f1){#f1-ehp0114s1-000134}

![. Experimental design for testing the effects of partial E~2~ exposure on sex differentiation in *X. laevis* larvae. The larval period from hatching \[NF stage (St.) 48\] to the completion of metamorphosis (complete tail reabsorption, NF stage 66) lasts 65 days on average under standard conditions in our laboratory. Sex differentiation occurs between NF stages 52 and 54 (\~ 25 days posthatching). Animals were treated with E~2~ (100 μg/L) for 7 days (beginning at NF stage 50, day 19 posthatching, and ending at NF stage 53, day 26), for 14 days (beginning at NF stage 50, day 19 posthatching, and ending at NF stage 55, day 33), or 49 days (until complete tail reabsorption, NF stage 66). Treatment periods are shown by the solid green horizontal arrows, and termination of treatments, by the vertical dashed lines. In the final experimental group, treatment ended for each individual as they metamorphosed. Black arrows indicate that the animals were reared without E~2~ exposure after the treatments were completed. Larval pictures adapted from [@b61-ehp0114s1-000134].](ehp0114s1-000134f2){#f2-ehp0114s1-000134}

![Gonads of a control postmetamorphic (NF stage 66) male (*A*,*C*) and female (*B*,*D*) African clawed frog (*X. laevis*). Abbreviations: OV, ovarian vesicle; K, kidney. (*A*,*B*) The entire kidney--interrenal--gonadal complex. The yellow color is the result of Bouin's fixative. Arrowheads show the rostral and caudal ends of the animal's right gonad. (*C*,*D*) Transverse cross-sections (8 μm) through the geometric center of each animal's right gonad. Sections were stained with Mallory's trichrome stain. Arrow indicates melanophore in the ovary. Scale bar: (*A,B*) 0.1 mm; (*C,D*) 10 μm. Figure adapted from [@b31-ehp0114s1-000134].](ehp0114s1-000134f3){#f3-ehp0114s1-000134}

![Gonads of an NF stage 66 male *X. laevis* showing SSP. The individual shown was exposed to 0.1 ppb atrazine. (*A*) The entire dissected Bouin's-fixed kidney--interrenal--gonadal complex. Each of the six testes is numbered. (*B*,*C*) Sagittal sections (stained in Mallory's trichrome stain) through the animal's right and left gonad, respectively. The six testes are numbered corresponding to numbers in *A*. Each is a distinct organ based on review of the entire series of sagittal sections. Scale bar: (*A*,*B*) 0.1 mm; (*C*) 40 μm.](ehp0114s1-000134f4){#f4-ehp0114s1-000134}

![A mixed hermaphrodite at NF stage 66, treated with 0.1 ppb atrazine. Abbreviations: FB, fatbody; K, kidney; O, ovary; T, testis. (*A*) The entire dissected, Bouin's-fixed kidney--interrenal--gonadal complex. (*B*--*E*) Transverse cross-sections (8 μm) stained in Mallory's trichrome stain. Sections were taken through areas indicated by the black lines. Note the absence of pigment in the ovaries, a conditional typical in hermaphrodites. Scale bar: (*A*) 0.1 mm; (*B--E*) 25 μm.](ehp0114s1-000134f5){#f5-ehp0114s1-000134}

![A lateral hermaphrodite at NF stage 66, treated with 0.1 ppb atrazine. Abbreviations: O, ovary, T, testis. (*A*) The entire dissected, Bouin's-fixed kidney--interrenal--gonadal complex. (*B*) A transverse cross-section (8 μm) stained in Mallory's trichrome stain. The section was taken from the center of the gonad indicated by the arrow in *A*. Scale bar: (*A*) 0.1 mm; *B*) 25 μm.](ehp0114s1-000134f6){#f6-ehp0114s1-000134}

![A rostral-caudal hermaphrodite at NF stage 66, treated with 0.1 ppb atrazine. Abbreviations: K, kidney, O, ovary, T, testis. (*A*) The entire dissected, Bouin's-fixed kidney--interrenal--gonadal complex. (*B*,*C*) Transverse cross-sections (8 μm) of the animal's right gonad stained in Mallory's trichrome stain. The sections were taken from the areas shown by the white arrowheads: right rostral testis in cross-section (*B*) and right caudal ovary (*C*). (*D*--*G*) Sagittal sections (8 μm) taken from the animal's left gonad from the areas indicated by the white arrows: sagittal sections of the left rostral testis (*D*,*E*) and through the caudal ovary ( *F*,*G*). Note absence of pigment in the ovary. Scale bar: (*A*) 0.1 mm; (*B--C*) 10 μm; (*D--G*) 50 μm.](ehp0114s1-000134f7){#f7-ehp0114s1-000134}

![An animal with nonpigmented ovaries. The individual shown was exposed to 0.1 ppb atrazine. Abbreviations: K, kidney; O, ovary; UO, unpigmented ovaries. (*A*) The entire dissected, Bouin's-fixed kidney--interrenal--gonadal complex. Although the individual shown has distinct lobes, some animals with this morphology had only very shallow indications of lobes. (*B*) A transverse cross-section (8 μm) through the geometric center of the animal's kidney and gonads. The section is stained in Mallory's trichrome stain. This histology revealed that the animals were in fact females, even though their gonads lacked pigment, typical of normal ovaries. Scale bar: (*A*) 0.1 mm; (*B*) 40 μm.](ehp0114s1-000134f8){#f8-ehp0114s1-000134}

![(*A*) Frequency of males, females, and specimens with gonadal malformations in controls and atrazine-treated animals (0.1--25 ppb). Numbers above bars are samples sizes and represent the number surviving to metamorphosis (of 90). Dashed line indicates 50%. (*B*) Frequency of gonadal malformations only. *X*-axis is categorical.](ehp0114s1-000134f9){#f9-ehp0114s1-000134}

![Unpigmented ovaries induced by CPA exposure. Abbreviations: FB, fat body; K, kidneys; UO, unpigmented ovary. Scale bar = 0.1 mm.](ehp0114s1-000134f10){#f10-ehp0114s1-000134}

![Frequency of males, females, and animals with nonpigmented ovaries in animals exposed to CPA compared with solvent (methanol)-treated controls. Numbers above bars are samples sizes and represent the number surviving to metamorphosis (of 90). Dashed line indicates 50%.](ehp0114s1-000134f11){#f11-ehp0114s1-000134}

![SSP (*A*) and hermaphroditism (*B*) in animals treated for 7 days (NF stage 50--53) with 100 μg/L E~2~. Six testes (three on each side) are numbered in *A*. Abbreviations: O, ovary; T, testis. Scale bar = 0.1 mm for *A* and *B*.](ehp0114s1-000134f12){#f12-ehp0114s1-000134}

![Frequency of males, females, animals with SSP, and hermaphrodites in animals treated for s7, 14, or 49 days with 100 μg/L E~2~. *X*-axis is categorical. Control bar shows the control sex ratio. NF stages below the bars indicate the stage at which E~2~ exposure was terminated. All E~2~ exposures began at NF stage 50 ([Figure 2](#f2-ehp0114s1-000134){ref-type="fig"}). Numbers above bars are samples sizes and represent the number surviving to metamorphosis (of 90). Dashed line indicates 50%.](ehp0114s1-000134f13){#f13-ehp0114s1-000134}

###### 

Statistics for effects of atrazine on frequency of gonadal malformations.

  Atrazine (ppb)   *G*              *df*   *p*-Value
  ---------------- ---------------- ------ -----------
  0                −1.1 × 10^−13^   2      \> 0.995
  0.1              24.94            2      \< 0.001
  0.4              36.92            2      \< 0.001
  0.8              29.21            2      \< 0.001
  1.0              58.13            2      \< 0.001
  25               25.70            2      \< 0.001
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